Enhancing global laboratory systems to safely manage biological risks, deploy diagnostics, and sequence pathogens to improve capacities for global health threat response and detection
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract focuses on advancing global public health by strengthening laboratory systems worldwide. Key activities include enhancing laboratory infrastructure, improving workforce capabilities, advancing bio-risk management, and reinforcing emergency laboratory preparedness following the 7-1-7 outbreak response framework. The contract also aims to improve laboratory quality management systems and bolster diagnostic capacity through the deployment of rapid tests tailored for low-resource settings and genomic sequencing technologies for pathogens with pandemic potential. The initiative prioritizes continuity and expansion, encouraging previous recipients funded under a related CDC program to extend their efforts into additional countries, with special consideration for these applications. Managed by the Centers for Disease Control under the Department of Health and Human Services, this program is positioned to significantly enhance global capacities for detecting and responding to emerging health threats through improved laboratory safety, diagnostics, and pathogen sequencing capabilities.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Activities under this NOFO will focus on protecting and improving public health globally by: 1) strengthening public health laboratory systems; 2) improving public health laboratory workforce; 3) improving bio risk management; 4) reinforcing emergency laboratory preparedness in alignment with 7-1-7 outbreak response paradigm; 5) enhancing laboratory quality management systems and; 6) enhancing diagnostic capacity via rapid tests for low resource settings and genomic sequencing for pathogens of pandemic potential. Additionally, laboratory recipients previously funded under CDC-RFA-GH20-2109 may apply to expand efforts in additional countries with special consideration given to those countries.
